Ret 40 5340 Pill: gray, round
Generic Name: selpercatinib
The pill with imprint Ret 40 5340 (Gray, Round, 0mm) has been identified as Retevmo 40 mg and is used for Non Small Cell Lung Cancer, Thyroid Cancer, and Solid Tumors. It belongs to the drug class multikinase inhibitors and is not a controlled substance.
Images for Ret 40 5340
Retevmo
- Generic Name
- selpercatinib
- Imprint
- Ret 40 5340
- Strength
- 40 mg
- Color
- Gray (light gray)
- Shape
- Round (film-coated)
- Availability
- Prescription only
- Drug Class
- Multikinase inhibitors
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Eli Lilly and Company
- National Drug Code (NDC)
- 00002-5340
See also:
More about Retevmo (selpercatinib)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (4)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: multikinase inhibitors
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.